Clinical trial
An Evidence-based Strategy for Assessing the Risk of Significant Neonatal Hyperbilirubinemia
NCT01109277 is registered in ClinicalTrials.gov with University of Patras as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Evidence-based Strategy for Assessing the Risk of Significant Neonatal Hyperbilirubinemia
- Lead sponsor
- University of Patras
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- January 31, 2011
- Enrollment
- 3,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.